SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 1,809.51 |
| Enterprise Value ($M) | 1,552.44 |
| Book Value ($M) | 733.38 |
| Book Value / Share | 9.62 |
| Price / Book | 2.47 |
| NCAV ($M) | 732.79 |
| NCAV / Share | 9.61 |
| Price / NCAV | 2.47 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.12 |
| Return on Assets (ROA) | -0.15 |
| Return on Equity (ROE) | -0.15 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 35.30 |
| Current Ratio | 35.30 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 754.21 |
| Assets | 754.80 |
| Liabilities | 21.42 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 1.14 |
| Operating Income | -114.67 |
| Net Income | -88.04 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -78.71 |
| Cash from Investing | -300.76 |
| Cash from Financing | 628.28 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Decheng Capital Global Life Sciences Fund IV, L.P. | 8.40 | 16.72 | |
| 13G/A | Unique Diamond Investments Ltd | 5.50 | -24.19 | |
| 13G/A | Vanguard Group Inc | 7.57 | 0.00 | |
| 13G | BlackRock, Inc. | 5.30 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 416,135 | 1,406,082 | 29.60 | |
| 492,312 | 2,123,315 | 23.19 | |
| 431,248 | 3,108,629 | 13.87 | |
| 643,013 | 4,069,428 | 15.80 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CCCC – C4 Therapeutics, Inc. | CGC – Canopy Growth Corporation |
| CGEM – Cullinan Therapeutics, Inc. | COGT – Cogent Biosciences, Inc. |
| COLL – Collegium Pharmaceutical, Inc. |
Financial data and stock pages provided by
Fintel.io